Leslie Mershon

An unhydrolyzable analogue of N-(4-hydroxyphenyl)retinamide. synthesis and preliminary biological studies.

Mechanism of uterine vascular refractoriness to endothelin-1 in pregnant sheep.

Leptin in the ovine fetus correlates with fetal and placental size.

Design and implementation of a local Health Alert Network.

[Sequencing and cloning of human estrogen beta receptor (hERbeta) cDNA in human granulosa].

Chemotherapeutic evaluation of 4-hydroxybenzylretinone (4-HBR), a nonhydrolyzable C-linked analog of N-(4-hydroxyphenyl) retinamide (4-HPR) against mammary carcinogenesis.

Knowledge about typical source output influences perceived auditory distance.

The far-anchor effect: errors in the perception of motion and implications for aviation safety.

Estrogen increases iNOS expression in the ovine coronary artery.

Differential effects of selective estrogen receptor modulators and estrogens on mammary blood flow in the ovine.

Estrogen increases inducible nitric oxide synthase gene expression.

Be prepared. Important financial component of a medical practice.

The role of selective estrogen receptor modulators in the prevention of breast cancer: comparison of the clinical trials.

Role of raloxifene in breast cancer prevention in postmenopausal women: clinical evidence and potential mechanisms of action.

Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene.

Association of leptin with poor ovarian stimulation during in vitro fertilization.

Safety assessment of raloxifene over eight years in a clinical trial setting.

Hemodynamic effects of acute and repeated exposure to raloxifene in ovariectomized sheep.

Effect of raloxifene on the incidence of invasive breast cancer in postmenopausal women with osteoporosis categorized by breast cancer risk.

Risk factors for breast cancer in older women: the relative contribution of bone mineral density and other established risk factors.

Solid phase-assisted synthesis and screening of a small library of N-(4-hydroxyphenyl)retinamide (4-HPR) analogs.

4-Hydroxyphenylretinamide (4HPR) derivatives regulate aromatase activity and expression in breast cancer cells.

Relationship between bone mass, invasive breast cancer incidence and raloxifene therapy in postmenopausal women with low bone mass or osteoporosis.

Formation of lay sponsors. Seven leaders reveal their thoughts on the topic.

Review of comparative effectiveness of treatments to prevent fractures.

Reduced incidence of invasive breast cancer with raloxifene among women at increased coronary risk.

Characterization of biofilm matrix, degradation by DNase treatment and evidence of capsule downregulation in Streptococcus pneumoniae clinical isolates.

Raloxifene use in clinical practice: efficacy and safety.

Role of complement in protection against Cryptococcus gattii infection.

Incidence of invasive breast cancer in postmenopausal women after discontinuation of long-term raloxifene administration.

Patient characteristics and utilization of breast cancer screening or diagnostic procedures prior to initiation of raloxifene, bisphosphonates and calcitonin.

Tips for better visual elements in posters and podium presentations.

Compliance with mammography and bone mineral density screening in women at least 50 years old.

Cytoplasmic pH response to acid stress in individual cells of Escherichia coli and Bacillus subtilis observed by fluorescence ratio imaging microscopy.

The stomatopod dactyl club: a formidable damage-tolerant biological hammer.

Tibia shaft fractures: costly burden of nonunions.